Germany · Delayed Price · Currency is EUR Lifecore Biomedical Company Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures.
Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.
Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
| Country | United States |
| Founded | 1965 |
| Industry | Pharmaceutical Preparations |
| Employees | 406 |
| CEO | Paul Josephs |
Contact Details
Address: 3515 Lyman Boulevard Chaska, Delaware 55318 United States | |
| Phone | 952 368 4300 |
| Website | lifecore.com |
Stock Details
| Ticker Symbol | LDE |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Paul Josephs | Chief Executive Officer |
| Ryan Lake | Chief Financial Officer |
| Thomas Guldager | Chief Operating Officer |